Vote!
Etubics Enters Phase I Cancer Clinical Trials Focused On Colorectal Cancer
Etubics Corporation, a biopharmaceutical company developing "next generation" vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen (CEA)-expressing cancers such as colorectal cancer. ...
Published By : MedicalNews - Thursday, 29 July
- Older Health Info
- Vote! Light The White House Blue For Prostate Cancer Awareness Month
MedicalNews - Today
- Vote! Chemical In Widely Consumed Foods Linked To Skin Cancer
- Vote! Need For Cancer Information And Support Expected To Double, UK
- Vote! Diabetes Drug Might Fight Cancer
American Diabetes Association - Yesterday
- Vote! Clinical Trials Update: Sept. 3, 2010
(HealthDay)
Yahoo - Health - Yesterday
- Vote! Afferent Pharmaceuticals Presents Data Supporting Use Of P2X3 Antagonists In Reducing Bone Cancer Pain
- Vote! Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart With RHuPH20 In Type 1 And Type 2 Diabetes
- Vote! Macmillan's Response To NICE Decision On Liver Cancer Drug
- Vote! Cancer Patients Pay The Price To Keep Warm , UK
- Vote! Clinical Trials Update: Sept. 2, 2010
(HealthDay)
